Skip to interaction information
Ortaakarsu · Medicine information Source-based drug interaction reference · English

Darunavir and Digoxin (Digoxin Sandoz 0.25 mg): interaction and safety

This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.

Interaction mechanism

Transporter inhibition increases digoxin exposure.

Clinical significance and safety

For ritonavir-boosted darunavir (PREZISTA/ritonavir), digoxin concentrations and clinical effects require monitoring. The prescriber should review kidney function and toxicity symptoms rather than applying an isolated two-drug rule.

Using this information

This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.